Dr. Price is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 UCLA Medical Plz
Ste 2200
Los Angeles, CA 90095Phone+1 310-825-9989Fax+1 310-267-1908
Summary
- Collin Price, MD, is a Los Angeles-based psychiatrist specializing in Psychopharmacology. He completed his residency in 2023 at Ronald Reagan UCLA Medical Center after graduating from David Geffen School of Medicine at UCLA in 2019. Dr. Price has been prolific in his field, publishing a number of papers in reputable journals such as the Journal of Affective Disorders and The Medical Clinics of North America, among others. His published works cover a wide range of topics, including the potential benefits of psychedelic medicine, the role of the microbiome in psychiatric disorders, and the effects of SSRIs on MDMA-assisted therapy. Dr. Price's research has been frequently cited by other publications, exemplifying his contribution to the medical community.
Education & Training
- Ronald Reagan UCLA Medical CenterResidency, 2023
- David Geffen School of Medicine at UCLAClass of 2019
Certifications & Licensure
- CA State Medical License 2022 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 11 citationsThe need for establishing best practices and gold standards in psychedelic medicine.Allison Feduccia, Gabby Agin-Liebes, Collin M Price, Nicole Grinsell, Summer Paradise
Journal of Affective Disorders. 2023-07-01 - Microbiome in Anxiety and Other Psychiatric Disorders.Norman M Spivak, Jonathan Haroon, Andrew Swenson, Scott A Turnbull, Nolan Dang
The Medical Clinics of North America. 2023-01-01 - 4 citationsEffects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence...Collin M Price, Allison A Feduccia, Katrina DeBonis
Journal of Clinical Psychopharmacology. 2022-08-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: